CUA Educational Content

Case Studies in Prostate Cancer: Patient Pathways for Genetic Testing and Treatment


EDITORIAL COMMITTEE: Michael Kolinsky and Franciso Vera-Badillo


By the end of this program, participants will be able to:

  • Review treatment sequencing along patient pathway (prostate cancer patient cases)
  • Discuss practical considerations for tumor testing (who, when and how to test)
  • Target DNA repair defects in prostate cancer and the role of PARP inhibitors
 

 

This program has received financial support from AstraZeneca and Merck in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy